Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,723,422
+$13,322,550 QoQ
Shares Held
470,400
+4.3% QoQ
Ownership
0.499%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. TVTX ranks #15 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in TVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,723,422 | 470,400 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,400,872 | 451,056 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $20,515,903 | 536,925 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,442,147 | 520,592 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,554,333 | 510,428 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $7,399,740 | 412,932 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,375,533 | 78,963 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,132,600 | 80,958 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $610,250 | 74,240 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $579,429 | 75,153 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,212,319 | 134,852 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,537,161 | 171,942 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,081,863 | 135,538 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,816,467 | 125,232 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,583,410 | 75,293 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,578,980 | 64,082 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $547,621 | 22,601 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $557,765 | 21,644 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $662,579 | 21,346 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $515,021 | 21,238 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $152,055 | 10,422 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $289,975 | 11,613 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $269,688 | 9,895 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 RTRX | — | 9,981 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 RTRX | — | 10,047 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 RTRX | — | 9,820 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||